Clinical uses of Bupropion in patients with Parkinson’s disease and comorbid depressive or neuropsychiatric symptoms: a scoping review

OBJECTIVE: Bupropion, an antidepressant inhibiting the reuptake of dopamine and noradrenaline, should be useful to treat depressive symptoms in patients with Parkinson’s disease (PD). Limited and conflicting literature data questioned its effectiveness and safety in depressed PD patients and extende...

Descripción completa

Detalles Bibliográficos
Autores principales: Vismara, Matteo, Benatti, Beatrice, Nicolini, Gregorio, Cova, Ilaria, Monfrini, Edoardo, Di Fonzo, Alessio, Fetoni, Vincenza, Viganò, Caterina A., Priori, Alberto, Dell’Osso, Bernardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9069850/
https://www.ncbi.nlm.nih.gov/pubmed/35513785
http://dx.doi.org/10.1186/s12883-022-02668-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9069850/
https://www.ncbi.nlm.nih.gov/pubmed/35513785
http://dx.doi.org/10.1186/s12883-022-02668-4

Ejemplares similares